ICON plc vs Medpace

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/iconplc/medpace

Category	ICON plc	Medpace
Listed site	cro	cro
Summary	ICON is a world-leading clinical research organization providing outsourced services across the full clinical trial lifecycle, from early phase through commercialization, to pharmaceutical, biotechnology, and medical device companies.	Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Flow Cytometry Services Bioanalysis Translational Research Biomarker Assays Immunogenicity Assays (ADA / NAb) Ligand-Binding Bioanalysis (Large Molecule) LC-MS Bioanalysis (Small Molecule) Cardiovascular & Metabolic Specialty Services CNS Specialty Services Oncology Specialty Services Immunology & Inflammation Services Companion Diagnostics Development Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy	Clinical Operations Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Trial Services Biostatistics & Statistical Programming Data Management & eClinical Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs Central Laboratory Services Biomarker Assays Immunogenicity Assays (ADA / NAb) Bioanalysis Clinical Imaging Core Lab Microbiology Services Cardiovascular & Metabolic Specialty Services Oncology Specialty Services Immunology & Inflammation Services Virology Services US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Device & Combination Product Services Japan PMDA Regulatory Strategy CNS Specialty Services Ligand-Binding Bioanalysis (Large Molecule) In Vitro Pharmacology In Vitro ADME / DMPK Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Gene Therapy Cell Therapy Vaccine Radiopharmaceutical
Indications	Cardiovascular Neurology Immunology Oncology Infectious Disease Metabolic Rare Disease Women's Health Ophthalmology	Cardiovascular Dermatology Metabolic Gastroenterology Oncology Immunology Infectious Disease Nephrology Neurology Ophthalmology Respiratory Rare Disease Women's Health
Locations	Headquarters, Dublin, Ireland Belgium, Belgium, Belgium Bulgaria, Bulgaria, Bulgaria Germany, Germany, Germany Hungary, Hungary, Hungary Italy, Italy, Italy Netherlands, Netherlands, Netherlands Poland, Poland, Poland Romania, Romania, Romania Slovakia, Slovakia, Slovakia South Africa, South Africa, South Africa Spain, Spain, Spain Türkiye, Türkiye, Türkiye United Kingdom, United Kingdom, United Kingdom Australia, Australia, Australia China, China, China India, India, India Japan, Japan, Japan Korea, Korea, Korea Malaysia, Malaysia, Malaysia Taiwan, Taiwan, Taiwan Argentina, Argentina, Argentina Brazil, Brazil, Brazil Chile, Chile, Chile Colombia, Colombia, Colombia Mexico, Mexico, Mexico Belgium, Belgium, Belgium Bulgaria, Bulgaria, Bulgaria Germany, Germany, Germany Hungary, Hungary, Hungary Italy, Italy, Italy Netherlands, Netherlands, Netherlands Poland, Poland, Poland Romania, Romania, Romania Slovakia, Slovakia, Slovakia South Africa, South Africa, South Africa Spain, Spain, Spain Türkiye, Türkiye, Türkiye United Kingdom, United Kingdom, United Kingdom Australia, Australia, Australia China, China, China India, India, India Japan, Japan, Japan Korea, Korea, Korea Malaysia, Malaysia, Malaysia Taiwan, Taiwan, Taiwan Argentina, Argentina, Argentina Brazil, Brazil, Brazil Chile, Chile, Chile Colombia, Colombia, Colombia Mexico, Mexico, Mexico United States, United States, United States	Central Laboratories, Cincinnati, Ohio, United States Central Laboratory, Cincinnati, Ohio, United States Headquarters, Cincinnati, OH, USA Dallas, Irving, TX, USA Denver, Denver, CO, USA Mexico City, Mexico City, Distrito Federal, Mexico Leuven, Leuven, Flemish Brabant, Belgium Prague, Prague, Prague, Czech Republic Copenhagen, Copenhagen, Copenhagen, Denmark Lyon, Lyon, Auvergne-Rhône-Alpes, France Munich, Munich, Bavaria, Germany Budapest, Budapest, Budapest, Hungary Rehovot, Rehovot, Central, Israel Milan, Milan, Lombardy, Italy London, London, England, United Kingdom Maastricht, Maastricht, Limburg, Netherlands Rotterdam, Rotterdam, South Holland, Netherlands Warsaw, Warsaw, Masovian, Poland Johannesburg, Johannesburg, Gauteng, South Africa Dallas, Dallas, TX, USA Madrid, Madrid, Spain Mexico, Mexico City, Mexico City, Mexico
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.